Related Experiment Video
Updated: Aug 14, 2026
05:39
Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids
Published on: April 5, 2024
Molecular Biomarkers of Radiosensitivity and Radioresistance in Cervical Cancer: A Systematic Review
Anamaria Hermina Girbovan1,2, Cristina Balan3, Alexandra Timea Kirsch-Mangu1,4
1Department of Radiation Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
International Journal of Molecular Sciences
|August 13, 2026
Summary
Identifying molecular biomarkers for cervical cancer radiosensitivity is crucial. This review highlights DNA repair, stemness, hypoxia, and signaling pathways, suggesting multi-marker panels can improve treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy Research
Background:
- Cervical cancer treatment often involves radiotherapy, but patient response varies significantly.
- Understanding the molecular basis of radiosensitivity and radioresistance is key to optimizing treatment strategies.
Conclusions:
- Cervical cancer radiosensitivity is governed by a complex network of biological pathways.
- Validated, integrated biomarker panels assessing DNA repair, stemness, hypoxia, and signaling are needed for improved risk stratification and targeted radiosensitization.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...